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Summary
 Aim To present three cases treated with contact pulsed dose rate (PDR) brachyther-
apy using individually prepared moulds.
 Materials/Methods The study group included one case of hard palate cancer treated with brachy-
therapy, applied as a boost to external beam radical irradiation and two cases of 
recurrent ethmoid and maxillary sinus cancer in which we administered pallia-
tive brachytherapy as the sole treatment for tumours located within previously 
irradiated areas.
 Results Good fi tting of the moulds to the target was obtained. Satisfactory local control, 
including complete hard palate cancer remission for six years, and acceptable 
side effects were achieved.
 Conclusions Contact PDR brachytherapy using individually constructed moulds allows for the 
treatment of anatomical structures with diffi cult access. This method seems to be 
an effective and relatively safe treatment option for tumours located within pre-
viously irradiated areas.
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BACKGROUND
Pulsed dose rate (PDR) treatment is a new brach-
ytherapy technique that combines the physical 
advantages of high dose rate (HDR) technology 
(isodose optimization, radiation safety) and the 
radiobiological advantages of conventional low 
dose rate (LDR) brachytherapy.
In head and neck cancer, PDR brachytherapy can 
be performed as the sole treatment or as a boost 
to external beam radiotherapy (EBRT) [1–4]. 
PDR brachytherapy may be applied as an inter-
stitial, or contact treatment. A remote afterload-
er contains a single 192Ir source with the nominal 
activity of 0.5 or 1 Ci, whose stepped movement 
through the catheters, with dwell positions and 
times adjusted under precise computer control, 
provides the required dose distribution. The idea 
of PDR brachytherapy is to deliver the whole dose 
in a large number of small fractions within a few 
days, in order to approximate the advantageous 
radiobiological characteristics of LDR brachyther-
apy. This prolonged therapy, however, may result 
in undesirable catheter movement, increasing the 
risk of “geographical miss” in the target volume. 
The PDR technique maintains the main advan-
tages of brachytherapy: the rapid dose fall off be-
yond the implant volume and the possibility of 
dose optimization, allowing for adequate sparing 
of surrounding healthy tissues. Therefore, PDR 
brachytherapy represents an effective therapeu-
tic method in a number of cancer localizations, 
particulary in those within previously irradiated 
tissues [2,5–9].
Contact brachytherapy of head and neck cancer 
usually necessitates individual moulds. Precise ad-
aptation of the mould is necessary, in order to 
avoid undesirable applicator movements during 
therapy [10,11]. Clinical experience with the use 
of moulds for PDR brachytherapy is scarce.
AIM
In this paper, we present three cases of contact 
PDR brachytherapy using individually prepared 
moulds in primary and recurrent head and neck 
cancer.
MATERIALS AND METHODS
In all cases, impressions of the tumour/tumour 
bed and surrounding tissues were taken using ir-
reversible alginate hydrocolloid and, in two cas-
es, with additional polyvinylosiloxane two-layer 
material. From these, wax moulds were made on 
plaster models. The oncologist planned the lo-
cation of fl exible tubes which were temporarily 
fi xed into the wax mould to provide an appro-
priate location for a dental technician. Finally, a 
mould with plastic tubes was constructed in the 
dental laboratory by replacing wax with heat-
cured transparent acrylic resin (two cases) and 
temperature cured resin (one case).
Orthogonal x-ray fi lms (two cases) and com-
puted tomography (one case) of the moulds, 
with radiopaque markers positioned, were tak-
en. Digitized data was entered into the compu-
ter planning system (PLATO, version 14.1). The 
target volume was defi ned as the volume encom-
passing the tumour/tumour bed with a margin 
of approximately 1–2 cm, specifi ed by the partic-
ipating physician. The dosimetry was calculated 
using volume optimization techniques.
In all cases, stable fi xation of the moulds, pre-
venting undesirable movements, was achieved. 
In one case, after the initial setting of the mould 
in patient’s mouth, the movement of a dummy 
source was blocked by a blood clot inside a cath-
eter, which had to be replaced. The replacement 
of the perforated tube was possible without dam-
aging the mould. There were no other problems 
with source movement.
CASE REPORTS
Case 1
K. G, a 71 year old woman, was diagnosed with 
locally advanced squamous cell carcinoma of the 
hard palate, T4N0M0 according to the UICC clas-
sifi cation, underwent radiotherapy consisting of 
EBRT (60 Gy in 30 fractions). One week after 
EBRT completion a boost of contact PDR brach-
ytherapy using an individually prepared mould 
– a palate plate containing three catheters - was 
administered (Figure 1). A dose of 15 Gy (0.6 Gy 
per pulse repeated every hour) was delivered.
Three weeks after radiotherapy completion the 
patient developed confl uent fi brinous mucositis 
(Grade 3 according to RTOG Acute Morbidity 
Scoring Criteria). A signifi cant reduction of this 
acute side effect was achieved with a local antisep-
tic mouth rinse and administration of antibiot-
ics. Four months after treatment completion, the 
patient developed a severe complication (grade 
4 according to RTOG/EORTC scale) – 1×2 cm 
necrosis of the mucous membrane in the central 
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part of hard palate. Histological examination of 
the excised tissue revealed no cancer cells. No 
recurrence was observed during subsequent fi ve 
years. Telangiectasia, grade 3 in the fi rst year af-
ter irradiation (Figure 2), which subsequently 
decreased to grade 2, was the only observed late 
side effect. No bone changes were observed at a 
radiological examination performed three years 
after therapy.
The patient underwent prosthetic rehabilitation 
using an acrylic denture with a special underlying 
tissue conditioner on the palatal side (Figure 3). 
Once annually, denture correction with replace-
ment of the conditioner was necessary, owing to 
undesirable hardening of the material and be-
cause of its porosity, facilitating bacterial and fun-
gal colonization.
Case 2
D. H, a 77 year old man, developed recurrent sq-
uamous cell carcinoma rT4N0M0 of the maxillary 
sinus fi ve years after EBRT, of total dose 70 Gy 
(Figure 4). Due to being in poor general condi-
tion, radical tumour resection was impossible. 
The patient underwent contact PDR brachyther-
apy with the use of an individually prepared pal-
ato-maxillary mould (plate) with 7 plastic tubes 
located in appropriate order inside (Figures 5,6). 
The patient received a dose of 50 Gy, 0.6 Gy per 
pulse, repeated every hour. There was no tumor 
progression within the fi rst 6 months after re-irra-
diation. No serious acute or late side effects were 
observed, however the patient’s quality of life was 
poor owing to diffi culties in eating and speaking 
caused by a huge tumour bed perforating the na-
sal cavity. Prosthetic rehabilitation with a special 
obturating denture is in progress.
Case 3
D. J, a 61 year old man, was diagnosed with local 
recurrence of squamous cell carcinoma of the left 
ethmoid sinus two years after defi nitive EBRT at a 
dose of 66 Gy (Figure 7). The patient underwent 
surgical resection of relapsed tumour, but clear 
margins were not achieved. Salvage PDR contact 
Figure 1. Individually prepared mould – palate plate with three 
catheters for BT PDR.
Figure 2. Teleangiectasia grade 3 in the fi rst year after irradiation, 
patient K.G.
Figure 3. Prosthetic rehabilitation patient K.G.
Figure 4. Recurrent squamous cell carcinoma of the maxillary 
sinus, patient D.H.
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brachytherapy using an individually constructed 
mould and a dose of 30 Gy (0.6 Gy/puls/hour) was 
performed (Figures 8,9). No serious acute or late 
side effects were observed and neither was there 
any local recurrence of the tumour. Six months af-
ter completion of brachytherapy, the patient died 
of a second primary malignancy (lung cancer).
DISCUSSION
Salvage treatment options for previously irradi-
ated head and neck cancer patients are limited. 
Radical tumor resection with clear resection mar-
gins is diffi cult to accomplish, and repeated EBRT 
carries a high risk of severe side effects.
In the cases presented here, individually construct-
ed moulds for contact brachytherapy allowed the 
treatment of anatomical structures with diffi cult 
access. The use of this method necessitates the 
close cooperation of oncologists, oral surgeons 
and prosthodontists. Modern dental impression 
materials allow for the preparation of precise plas-
ter models of the tumor bed and for the prepara-
tion of moulds with stable adaptation. Appropriate 
catheters embedded in a mould, good fi tting of 
the mould to the target, and optimization of treat-
ment planning provide good dose distribution and 
safety in cases of contact PDR brachytherapy.
Figure 5. Individually prepared palato-maxillary mould (plate).
Figure 6. Individually prepared palato-maxillary mould (plate), 
patient D.H.
Figure 7. Local recurrence of squamous cell carcinoma of the left 
ethmoid sinus, patient D.J.
Figure 8. Individually constructed orbit mould.
Figure 9. Individually constructed orbit mould, patient D.J.
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CONCLUSIONS
Contact PDR brachytherapy using individually 
constructed moulds allows for the treatment of 
anatomical structures with diffi cult access. This 
method seems to be an effective and relatively 
safe treatment option for recurrent or persist-
ent tumours located within previously irradiat-
ed areas.
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